R+CU'S CANCER TREATMENT PROMISE: HOPE OR HYPE?
Healthcare Radius|April 2024
Tata Memorial Center’s proposed cancer pill claims to tackle recurrence, but human trials are needed for confirmation, says the author.
Dr M Balasubramanyam, PhD, FAMS, MNASc, FAPASc, FASCh
R+CU'S CANCER TREATMENT PROMISE: HOPE OR HYPE?

What can be termed a medical breakthrough, the researchers at the Tata Memorial Center of Mumbai have developed a new, affordable cancer treatment that can prevent cancer from recurring. The promising new cancer treatment is in the form of a ₹100 prooxidant tablet containing resveratrol and copper (R+Cu). This tablet targets a potential cause of cancer recurrence: cell fragments, cell-free chromatin particles (cfChPs), released by dying cancer cells that can trigger cancer in healthy cells. Containing resveratrol and copper, R+Cu generates oxygen radicals in the stomach that enter the bloodstream and destroy these cfChPs.

In pre-clinical trials on rats, R+Cu showed a 50 percent reduction in chemotherapy and radiation side effects. While early results suggest a 30 percent effectiveness in preventing cancer recurrence, human trials for prevention are still needed. This breakthrough offers hope for improved cancer treatment affordability and reduced patient burden. The tablet awaits approval from India’s food safety agency and could be available for human clinical trials by June-July 2024 if successful. 

EXAMINING THE RESEARCH

Bu hikaye Healthcare Radius dergisinin April 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye Healthcare Radius dergisinin April 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

HEALTHCARE RADIUS DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
KIMSHEALTH launches electrophysiology lab with 3D mapping
Healthcare Radius

KIMSHEALTH launches electrophysiology lab with 3D mapping

'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.

time-read
1 min  |
November 2024
Molbio boosts Goa's healthcare system with CSR initiatives
Healthcare Radius

Molbio boosts Goa's healthcare system with CSR initiatives

The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies

time-read
1 min  |
November 2024
USV introduces affordable heart failure medication
Healthcare Radius

USV introduces affordable heart failure medication

This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.

time-read
1 min  |
November 2024
City Imaging & Clinical Labs to expand services to 50 hospitals
Healthcare Radius

City Imaging & Clinical Labs to expand services to 50 hospitals

The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.

time-read
1 min  |
November 2024
Oncare raises $1 million in seed funding, to set up 10 units
Healthcare Radius

Oncare raises $1 million in seed funding, to set up 10 units

Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.

time-read
1 min  |
November 2024
Nutrabay forays into Ayurvedic supplements market with Shilajit
Healthcare Radius

Nutrabay forays into Ayurvedic supplements market with Shilajit

Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.

time-read
1 min  |
November 2024
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
Healthcare Radius

INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY

The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.

time-read
8 dak  |
November 2024
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Healthcare Radius

TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES

Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.

time-read
3 dak  |
November 2024
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
Healthcare Radius

BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY

As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.

time-read
8 dak  |
November 2024
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
Healthcare Radius

LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION

In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?

time-read
3 dak  |
November 2024